Denali Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 151.1 | 119.3 | 172.4 | 207.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 3.3 | 12.1 | 9.6 | 13.7 | 15.7 | 16.6 | 14.7 | 9.9 | 62.7 | 68.7 | 92.3 | 163.6 | 32.0 | 20.3 | 27.0 | 17.4 | 112.0 | 47.7 | 32.2 | 34.2 | 34.1 | 30.9 | 12.1 | 8.3 | 116.6 | – | – | – | – | – | – | – | – | – | 1,335.7 | |
| – | – | – | – | – | 1.0 | 3.3 | 2.9 | 4.4 | 3.7 | 4.3 | 4.2 | 3.3 | 4.2 | 3.3 | 5.1 | 4.4 | 9.3 | 6.2 | 9.0 | 6.1 | 5.7 | 4.3 | 4.1 | 4.7 | 3.5 | 3.2 | 3.5 | 2.5 | 2.9 | 2.1 | 2.8 | 3.7 | 2.8 | 2.1 | 2.3 | 2.7 | 2.9 | 3.9 | 5.8 | |
| – | – | – | – | – | – | 11.9 | 9.5 | 13.5 | 15.2 | 16.8 | 14.4 | 9.5 | 59.8 | 60.9 | 87.5 | 148.9 | 30.5 | 19.0 | 25.7 | 16.3 | 106.1 | 46.5 | 30.8 | 33.2 | 32.1 | 30.3 | 11.8 | 7.9 | 111.9 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 143.8 | 107.9 | 151.1 | 159.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 43.3 | – | – | – | – | – | – | – | 26.0 | 16.6 | 23.9 | 17.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -16.6% | -1.5% | -3.6% | -3.2% | 2.3% | -0.8% | -1.5% | -1.9% | -10.1% | -10.7% | -7.1% | -3.9% | 3.8% | 6.0% | 4.2% | 5.9% | -4.0% | -6.2% | -6.5% | -6.7% | -7.1% | -7.9% | -7.7% | -12.3% | -12.5% | -13.9% | -10.3% | -7.6% | -10.5% | -16.5% | -15.3% | -16.4% | -14.6% | -11.7% | -9.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | 61.4% | 74.3% | 87.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 91.5% | – | – | – | – | – | – | – | – | – | -2,889.8% | |
| – | – | – | – | – | -62.1% | -64.6% | -87.5% | -97.3% | -35.9% | -47.6% | -50.6% | -54.6% | -799.1% | -884.5% | -826.5% | -1,016.8% | 18.7% | 15.1% | 14.3% | 7.2% | -607.8% | -351.1% | -258.5% | -282.3% | -314.2% | -389.4% | -47.6% | -49.7% | -771.7% | – | – | – | – | – | – | – | – | – | -15,058.2% | |
| – | – | – | – | – | -60.8% | -62.1% | -83.5% | -91.9% | -28.1% | -38.8% | -40.8% | -44.7% | -740.7% | -826.0% | -778.3% | -968.6% | 21.2% | 17.0% | 15.7% | 8.4% | -597.2% | -344.8% | -252.5% | -273.3% | -300.6% | -365.2% | -37.4% | -36.5% | -569.8% | – | – | – | – | – | – | – | – | – | -14,191.2% | |
| – | – | – | – | – | -54.8% | -18.4% | -34.6% | -43.3% | 36.2% | -14.1% | -22.0% | -18.5% | -635.3% | -738.3% | -659.1% | -638.2% | 123.1% | 122.2% | 113.2% | 102.4% | -451.9% | -293.2% | -208.0% | -229.1% | -242.1% | -244.4% | -93.6% | -102.0% | -1,455.3% | – | – | – | – | – | – | – | – | – | -12,138.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | -34.0% | -35.2% | -43.8% | -43.8% | -18.9% | -16.8% | -25.1% | -29.6% | -6.6% | -10.0% | -11.6% | -15.1% | -50.0% | -39.5% | -43.0% | -25.8% | 6.2% | 5.2% | 5.2% | 2.9% | -30.2% | -31.1% | -32.1% | -37.3% | -31.3% | -38.3% | -10.8% | -11.1% | -14.1% | -9.4% | -30.3% | -32.4% | -34.4% | -40.4% | -46.6% | -53.8% | -50.6% | -54.9% | -61.2% | |
| – | -32.0% | -38.7% | -40.4% | -40.3% | -18.1% | -14.7% | -21.5% | -25.1% | -5.5% | -7.6% | -8.7% | -11.0% | -35.7% | -31.0% | -33.3% | -21.3% | 4.4% | 3.7% | 3.7% | 2.0% | -20.7% | -21.6% | -22.0% | -24.6% | -22.3% | -26.3% | -9.8% | -10.1% | -12.6% | -8.7% | -27.9% | -29.4% | -30.8% | -35.7% | -41.1% | -47.2% | -44.8% | -40.1% | -44.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -37 | -20 | -28 | -58 | 33 | -45 | -60 | -76 | -203 | -133 | -347 | -502 | -430 | -481 | -389 | -288 | -99 | -149 | -112 | -211 | -62 | -125 | -141 | -120 | -53 | -67 | -83 | -163 | -48 | -132 | -82 | -196 | -378 | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.1 | -7.2 | -7.9 | -10.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 93.9% | 110.0% | 92.2% | 91.8% | 95.7% | 87.8% | 85.7% | 84.7% | 82.6% | 76.4% | 74.5% | 72.7% | 71.4% | 78.4% | 77.6% | 82.5% | 71.7% | 71.4% | 71.0% | 69.8% | 68.5% | 69.5% | 68.4% | 66.1% | 71.4% | 68.6% | 90.9% | 90.4% | 89.3% | 92.1% | 92.3% | 90.7% | 89.5% | 88.3% | 88.1% | 87.7% | 88.5% | 73.2% | 72.1% | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -12.38 | -9.61 | -9.94 | -1.37 | -1.03 | -2.87 | -1.01 | -1.33 | -1.46 | -0.37 | -0.54 | -0.58 | -0.69 | -2.06 | -2.10 | -2.04 | -2.12 | 0.55 | 0.48 | 0.45 | 0.24 | -2.38 | -2.33 | -2.31 | -2.45 | -2.45 | -2.71 | -0.91 | -0.90 | -1.05 | -0.92 | -2.49 | -2.52 | -2.49 | -2.65 | -2.79 | -2.89 | -2.92 | -2.72 | -2.73 | |
| – | – | – | – | 0.00 | 4.72 | 1.63 | 1.59 | 1.59 | 1.32 | 1.40 | 1.42 | 1.54 | 0.28 | 0.25 | 0.26 | 0.22 | 2.62 | 2.81 | 2.90 | 2.90 | 0.40 | 0.68 | 0.91 | 0.90 | 0.82 | 0.74 | 2.43 | 2.48 | 0.18 | -0.06 | -1.80 | -1.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| – | 28.23 | 28.23 | 3.13 | 2.34 | 15.15 | 6.02 | 5.28 | 4.92 | 5.59 | 5.44 | 4.98 | 4.57 | 4.11 | 5.32 | 4.75 | 8.21 | 8.97 | 9.14 | 8.72 | 8.31 | 7.88 | 7.48 | 7.19 | 6.57 | 7.85 | 7.08 | 8.42 | 8.12 | 7.46 | 9.74 | 8.22 | 7.78 | 7.23 | 6.56 | 5.99 | 5.37 | 5.78 | 4.96 | 4.46 | |
| – | -8.70 | -8.99 | -1.20 | -0.98 | -2.59 | -0.30 | -0.55 | -0.69 | 0.48 | -0.20 | -0.31 | -0.29 | -1.76 | -1.88 | -1.73 | -1.40 | 3.22 | 3.44 | 3.28 | 2.97 | -1.80 | -1.98 | -1.90 | -2.05 | -1.98 | -1.82 | -2.28 | -2.52 | -2.68 | -2.85 | -2.38 | -2.22 | -2.14 | -2.24 | -2.15 | -2.38 | -2.41 | -2.25 | -2.34 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.